ICH Expansion To Bring New Challenges For Global Consensus On Pediatric Extrapolation

The pharmaceutical industry is cautiously optimistic about the ambitious three-year timeline decided by the International Council for Harmonisation for its new guideline on pediatric extrapolation. However, ensuring consensus on this fast-developing concept will be a challenge as more regulators will have a seat at the discussion table as ICH expands.

Extrapolation
ICH Working Group On Pediatric Extrapolation Will Meet In Geneva In November • Source: Shutterstock

Work on the first ever detailed international guideline on pediatric extrapolation is due to begin shortly, but achieving consensus on this much-debated topic will not be an easy task for the International Council for Harmonisation, which is expanding its membership with the result that more regulators are expected to join the discussion, AstraZeneca's Solange Corriol-Rohou told a conference in London last week.

The topic of pediatric extrapolation was briefly touched upon in a recently finalized ICH guideline - E11(R1), which is an addendum to the ICH's existing 17-year-old guideline on the clinical investigation of medicinal products in the pediatric population

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Safety

More from Pink Sheet

Pink Sheet Podcast: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns

 

Pink Sheet editors discuss the appointment of Vinay Prasad as the new director of the Center for Biologics Evaluation and Research and revelations that FDA layoffs now are hindering development of guidance documents.

US FDA Restoring Some Library Resources

 

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals, and laid off librarians have not been reinstated.

Recent and Upcoming FDA Advisory Committee Meetings

 
• By 

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.